Results 261 to 270 of about 1,142,563 (307)

Opioid System Antagonism Alters Vascular Proteome and Collagen Deposition in ApoE^-/- Mice. [PDF]

Cells
Jaskuła K, Nawrocka A, Poznański P, Stachowicz A, Łazarczyk M, Sacharczuk M, Skiba DS.   +6 more
europepmc   +1 more source

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol. [PDF]

Addict Sci Clin Pract
Freet CS, Shuler K, Kawasaki S, Weintraub E, Greenblatt A, Kladney M, Nunes E, Foster KL, Kong L, Raja-Khan N, Cleveland HH, Grigson PS, Bunce SC, Brick TR, Nyland JE.   +14 more
europepmc   +1 more source

Review of the potential health impact of ß-casomorphins and related peptides: Report of the DATEX Working Group on ß-casomorphins [PDF]

FitzGerald, R.J., Korhonen, H.J.T., Livesey, C.T., Noni, I., De, Roux, Y., Le, Thorsdottir, I., Tomé, D., Witkamp, R.F.   +7 more
core  

Unlocking Casein Bioactivity: Lactic Acid Bacteria and Molecular Strategies for Peptide Release. [PDF]

Int J Mol Sci
Huang C, Cheng L.
europepmc   +1 more source

Comparison of the binding characteristics of tritiated opiates and opioid peptides [proceedings].

, 1979
Maureen Gc Gillan, H. W. Kosterlitz, Sue Paterson   +2 more
openalex   +1 more source

Atypical activation and molecular glue-like dimerization mechanism of an intrinsically-biased chemokine receptor

Banerjee N, Ganguly M, Reyaz A, Mishra S, Dalal A, Guo X, Qiu X, Meyrath M, Palmer CB, Guo H, Song S, Sinha S, Roy N, Mukherjee D, Tiwari D, Yadav MK, Chevigne A, Robinson CV, Chen X, Banerjee R, Shukla AK.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.

Molecular Pharmaceutics, 2013
A. Lindqvist, J. Rip, P. Gaillard, S. Björkman, M. Hammarlund-Udenaes   +4 more
semanticscholar   +1 more source

Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKAy mice.

American Journal of Physiology. Endocrinology and Metabolism, 2012
Yuko Yamada, A. Muraki, M. Oie, Norimasa Kanegawa, A. Oda, Yurina Sawashi, Kentaro Kaneko, M. Yoshikawa, T. Goto, N. Takahashi, T. Kawada, Kousaku Ohinata   +11 more
semanticscholar   +1 more source